Novartis, Moderna detail manufacturing expansions in the US, among othersnews2025-11-20T17:56:16+00:00November 20th, 2025|Endpoints News|
FDA approves new indication and monthly dose of Regeneron’s Eylea HDnews2025-11-20T14:14:22+00:00November 20th, 2025|Endpoints News|
New report suggests America must wean off China APIsnews2025-11-18T20:37:33+00:00November 18th, 2025|Endpoints News|
New US trade deal caps Switzerland, Liechtenstein pharma tariffs at 15%news2025-11-17T19:14:06+00:00November 17th, 2025|Endpoints News|
Scholar Rock plans to launch spinal muscular atrophy drug next yearnews2025-11-17T17:48:23+00:00November 17th, 2025|Endpoints News|
Onshoring and data ‘fidelity’: What FDA wants from generic drug user fee talksnews2025-11-14T20:47:05+00:00November 14th, 2025|Endpoints News|
Abeona’s skin disease cell therapy launch stymied by false-positive sterility testnews2025-11-13T15:43:19+00:00November 13th, 2025|Endpoints News|
Merck KGaA still in tariff talks with the White House, weeks after deal was announced news2025-11-13T14:29:36+00:00November 13th, 2025|Endpoints News|
WuXi AppTec plants ‘flag down’ in Europe with new Munich headquarters news2025-11-12T17:39:33+00:00November 12th, 2025|Endpoints News|
CDMOs don’t expect immediate impact from ‘most favored nation’ dealsnews2025-11-11T16:04:01+00:00November 11th, 2025|Endpoints News|
